This result demonstrates that NHF1TRAIL cells encapsulated in GelMA via CLIP 3DBP remain therapeutically active in vivo and suggests that secreted TRAIL from encapsulated cells can diffuse to nearby tumor foci to induce killing. This evidence concerns the gene TNFSF10 and neoplasm.